Increased whole blood chemiluminescence in patients with Shwachman syndrome: therapy trial with thiamine and alpha-tocopherol.
Neutrophils purified from peripheral blood of patients with the Shwachman syndrome show enhanced chemiluminescence (CL) and depressed chemotaxis. Here we present data showing that the increased CL response can be demonstrated by using a whole blood CL assay. This assay is well-suited for studies in infants, because the blood sample volumes needed are small. Increase in CL was most distinct in the initial (1 min) activation induced by N-formyl-methionyl-leucyl-phenylalanine. The 1-min response is considered to derive from extracellular production of oxygen radicals. Such an extracellular oxygen radical production may render the patients susceptible to undue oxidant stress. We therefore treated the patients with two antioxidants, thiamine and alpha-tocopherol, for 3 months. This supplementation, however, failed to exert any significant effect on either whole blood CL or migration of the patients' neutrophils under agarose.
Ristola
M
M
Department of Bacteriology and Immunology, University of Helsinki, Finland.
Savilahti
E
E
Leirisalo-Repo
M
M
Repo
H
H
D000975:Antioxidants / Q000494:pharmacology* / Q000627:therapeutic use; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D003550:Cystic Fibrosis / Q000188:drug therapy; D004359:Drug Therapy, Combination; D010188:Exocrine Pancreatic Insufficiency / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D008163:Luminescent Measurements; D009503:Neutropenia / Q000188:drug therapy*; D009504:Neutrophils / Q000187:drug effects*; D013577:Syndrome; D013831:Thiamine / Q000494:pharmacology* / Q000627:therapeutic use; D024505:Tocopherols; D014810:Vitamin E / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D024502:alpha-Tocopherol / Q000031:analogs & derivatives*
D000975:Antioxidants; D014810:Vitamin E; D024502:alpha-Tocopherol; D024505:Tocopherols; D013831:Thiamine